Loading…
Effects of racecadotril and loperamide on bacterial proliferation and on the central nervous system of the newborn gnotobiotic piglet
Methods The effects of 4 days of oral administration of different doses of two drugs, an enkephalinase inhibitor (the antisecretory agent, racecadotril) and a μ‐receptor agonist (loperamide), on intestinal growth of a bacterial nonpathogenic strain (Escherichia coli E 404) and on the central nervous...
Saved in:
Published in: | Alimentary pharmacology & therapeutics 1999-12, Vol.13 (s6), p.9-14 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4052-1cf3fdeeb99e1acf95ca46a0ac273cf0d85285dda24c9e7cb9b0838301ac51d3 |
---|---|
cites | |
container_end_page | 14 |
container_issue | s6 |
container_start_page | 9 |
container_title | Alimentary pharmacology & therapeutics |
container_volume | 13 |
creator | Duval‐Iflah, Y. Berard, H. Baumer, P. Guillaume, P. Raibaud, P. Joulin, Y. Lecomte, J.M. |
description | Methods The effects of 4 days of oral administration of different doses of two drugs, an enkephalinase inhibitor (the antisecretory agent, racecadotril) and a μ‐receptor agonist (loperamide), on intestinal growth of a bacterial nonpathogenic strain (Escherichia coli E 404) and on the central nervous system (CNS) were compared in newborn gnotobiotic piglets.
Results The E. coli content of the proximal jejunum (segment S1) and the E. coli ratio of stomach:segment S1 were similar in the racecadotril (20 mg/kg b.d., n = 5) and control groups. In contrast, in the loperamide group (1 mg/kg b.d., n = 4), the E. coli content of segment S1 and the E. coli ratio stomach:S1 were both significantly higher than with racecadotril or control (P = 0.04 and 0.005, respectively, for E. coli content; P = 0.05 and 0.03, respectively, for stomach:S1). There were no clinical signs of neurotoxicity and no deaths with racecadotril given orally at a high dose of 130 mg/kg b.d. (n = 5) – nearly 60 times the paediatric dosage. In contrast, an equivalent high dose of loperamide (5 mg/kg b.d.) resulted in death in three out of four piglets.
Conclusions In contrast to loperamide, racecadotril did not induce bacterial overgrowth and did not produce central neurotoxicity. |
doi_str_mv | 10.1046/j.1365-2036.1999.00001.x-i1 |
format | article |
fullrecord | <record><control><sourceid>wiley_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_02696176v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>APT2</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4052-1cf3fdeeb99e1acf95ca46a0ac273cf0d85285dda24c9e7cb9b0838301ac51d3</originalsourceid><addsrcrecordid>eNqVkc2KFDEUhYMoTjv6ChJw5aLK_FSlK4iLZhgdoUEXvQ-p5GYmTXWlSDI__QC-t4klg1vv5sI93zmLcxH6QElLSSc-HVvKRd8wwkVLpZQtKUPbp8bTF2jzrL1EG8KEbNhA-QV6k9KxYGJL2Gt0QYnoRMnaoF_XzoHJCQeHozZgtA05-gnr2eIpLBD1yVvAYcajNhmi1xNeYpi8K1L25V7JsvIdYANzjgWYIT6E-4TTOWU41eyqzvA4hjjj2znkMPqQvcGLv50gv0WvnJ4SvPu7L9Hh6_Xh6qbZ__j2_Wq3b0xHetZQ47izAKOUQLVxsje6E5pow7bcOGKHng29tZp1RsLWjHIkAx84KXBPLb9EH9fYOz2pJfqTjmcVtFc3u72qt1qYoFvxQAv7eWVNDClFcM8GSlT9gzqq2rWqXav6B_XnD-pJ-ep-v7qX-_EE9h_vWnwBvqzAo5_g_D_ZavfzwPhvZCya_A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Effects of racecadotril and loperamide on bacterial proliferation and on the central nervous system of the newborn gnotobiotic piglet</title><source>Wiley</source><creator>Duval‐Iflah, Y. ; Berard, H. ; Baumer, P. ; Guillaume, P. ; Raibaud, P. ; Joulin, Y. ; Lecomte, J.M.</creator><creatorcontrib>Duval‐Iflah, Y. ; Berard, H. ; Baumer, P. ; Guillaume, P. ; Raibaud, P. ; Joulin, Y. ; Lecomte, J.M.</creatorcontrib><description>Methods The effects of 4 days of oral administration of different doses of two drugs, an enkephalinase inhibitor (the antisecretory agent, racecadotril) and a μ‐receptor agonist (loperamide), on intestinal growth of a bacterial nonpathogenic strain (Escherichia coli E 404) and on the central nervous system (CNS) were compared in newborn gnotobiotic piglets.
Results The E. coli content of the proximal jejunum (segment S1) and the E. coli ratio of stomach:segment S1 were similar in the racecadotril (20 mg/kg b.d., n = 5) and control groups. In contrast, in the loperamide group (1 mg/kg b.d., n = 4), the E. coli content of segment S1 and the E. coli ratio stomach:S1 were both significantly higher than with racecadotril or control (P = 0.04 and 0.005, respectively, for E. coli content; P = 0.05 and 0.03, respectively, for stomach:S1). There were no clinical signs of neurotoxicity and no deaths with racecadotril given orally at a high dose of 130 mg/kg b.d. (n = 5) – nearly 60 times the paediatric dosage. In contrast, an equivalent high dose of loperamide (5 mg/kg b.d.) resulted in death in three out of four piglets.
Conclusions In contrast to loperamide, racecadotril did not induce bacterial overgrowth and did not produce central neurotoxicity.</description><identifier>ISSN: 0269-2813</identifier><identifier>EISSN: 1365-2036</identifier><identifier>DOI: 10.1046/j.1365-2036.1999.00001.x-i1</identifier><identifier>PMID: 10646046</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Animals ; Animals, Newborn ; Antidiarrheals - pharmacology ; Bacteria - drug effects ; Brain - drug effects ; Digestive System - microbiology ; Germ-Free Life ; Life Sciences ; Loperamide - pharmacology ; Loperamide - toxicity ; Neprilysin - antagonists & inhibitors ; Protease Inhibitors - pharmacology ; Swine ; Thiorphan - analogs & derivatives ; Thiorphan - pharmacology ; Thiorphan - toxicity</subject><ispartof>Alimentary pharmacology & therapeutics, 1999-12, Vol.13 (s6), p.9-14</ispartof><rights>Blackwell Science Ltd</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4052-1cf3fdeeb99e1acf95ca46a0ac273cf0d85285dda24c9e7cb9b0838301ac51d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10646046$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.inrae.fr/hal-02696176$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Duval‐Iflah, Y.</creatorcontrib><creatorcontrib>Berard, H.</creatorcontrib><creatorcontrib>Baumer, P.</creatorcontrib><creatorcontrib>Guillaume, P.</creatorcontrib><creatorcontrib>Raibaud, P.</creatorcontrib><creatorcontrib>Joulin, Y.</creatorcontrib><creatorcontrib>Lecomte, J.M.</creatorcontrib><title>Effects of racecadotril and loperamide on bacterial proliferation and on the central nervous system of the newborn gnotobiotic piglet</title><title>Alimentary pharmacology & therapeutics</title><addtitle>Aliment Pharmacol Ther</addtitle><description>Methods The effects of 4 days of oral administration of different doses of two drugs, an enkephalinase inhibitor (the antisecretory agent, racecadotril) and a μ‐receptor agonist (loperamide), on intestinal growth of a bacterial nonpathogenic strain (Escherichia coli E 404) and on the central nervous system (CNS) were compared in newborn gnotobiotic piglets.
Results The E. coli content of the proximal jejunum (segment S1) and the E. coli ratio of stomach:segment S1 were similar in the racecadotril (20 mg/kg b.d., n = 5) and control groups. In contrast, in the loperamide group (1 mg/kg b.d., n = 4), the E. coli content of segment S1 and the E. coli ratio stomach:S1 were both significantly higher than with racecadotril or control (P = 0.04 and 0.005, respectively, for E. coli content; P = 0.05 and 0.03, respectively, for stomach:S1). There were no clinical signs of neurotoxicity and no deaths with racecadotril given orally at a high dose of 130 mg/kg b.d. (n = 5) – nearly 60 times the paediatric dosage. In contrast, an equivalent high dose of loperamide (5 mg/kg b.d.) resulted in death in three out of four piglets.
Conclusions In contrast to loperamide, racecadotril did not induce bacterial overgrowth and did not produce central neurotoxicity.</description><subject>Animals</subject><subject>Animals, Newborn</subject><subject>Antidiarrheals - pharmacology</subject><subject>Bacteria - drug effects</subject><subject>Brain - drug effects</subject><subject>Digestive System - microbiology</subject><subject>Germ-Free Life</subject><subject>Life Sciences</subject><subject>Loperamide - pharmacology</subject><subject>Loperamide - toxicity</subject><subject>Neprilysin - antagonists & inhibitors</subject><subject>Protease Inhibitors - pharmacology</subject><subject>Swine</subject><subject>Thiorphan - analogs & derivatives</subject><subject>Thiorphan - pharmacology</subject><subject>Thiorphan - toxicity</subject><issn>0269-2813</issn><issn>1365-2036</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqVkc2KFDEUhYMoTjv6ChJw5aLK_FSlK4iLZhgdoUEXvQ-p5GYmTXWlSDI__QC-t4klg1vv5sI93zmLcxH6QElLSSc-HVvKRd8wwkVLpZQtKUPbp8bTF2jzrL1EG8KEbNhA-QV6k9KxYGJL2Gt0QYnoRMnaoF_XzoHJCQeHozZgtA05-gnr2eIpLBD1yVvAYcajNhmi1xNeYpi8K1L25V7JsvIdYANzjgWYIT6E-4TTOWU41eyqzvA4hjjj2znkMPqQvcGLv50gv0WvnJ4SvPu7L9Hh6_Xh6qbZ__j2_Wq3b0xHetZQ47izAKOUQLVxsje6E5pow7bcOGKHng29tZp1RsLWjHIkAx84KXBPLb9EH9fYOz2pJfqTjmcVtFc3u72qt1qYoFvxQAv7eWVNDClFcM8GSlT9gzqq2rWqXav6B_XnD-pJ-ep-v7qX-_EE9h_vWnwBvqzAo5_g_D_ZavfzwPhvZCya_A</recordid><startdate>199912</startdate><enddate>199912</enddate><creator>Duval‐Iflah, Y.</creator><creator>Berard, H.</creator><creator>Baumer, P.</creator><creator>Guillaume, P.</creator><creator>Raibaud, P.</creator><creator>Joulin, Y.</creator><creator>Lecomte, J.M.</creator><general>Blackwell Science Ltd</general><general>Wiley</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>1XC</scope></search><sort><creationdate>199912</creationdate><title>Effects of racecadotril and loperamide on bacterial proliferation and on the central nervous system of the newborn gnotobiotic piglet</title><author>Duval‐Iflah, Y. ; Berard, H. ; Baumer, P. ; Guillaume, P. ; Raibaud, P. ; Joulin, Y. ; Lecomte, J.M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4052-1cf3fdeeb99e1acf95ca46a0ac273cf0d85285dda24c9e7cb9b0838301ac51d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Animals</topic><topic>Animals, Newborn</topic><topic>Antidiarrheals - pharmacology</topic><topic>Bacteria - drug effects</topic><topic>Brain - drug effects</topic><topic>Digestive System - microbiology</topic><topic>Germ-Free Life</topic><topic>Life Sciences</topic><topic>Loperamide - pharmacology</topic><topic>Loperamide - toxicity</topic><topic>Neprilysin - antagonists & inhibitors</topic><topic>Protease Inhibitors - pharmacology</topic><topic>Swine</topic><topic>Thiorphan - analogs & derivatives</topic><topic>Thiorphan - pharmacology</topic><topic>Thiorphan - toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Duval‐Iflah, Y.</creatorcontrib><creatorcontrib>Berard, H.</creatorcontrib><creatorcontrib>Baumer, P.</creatorcontrib><creatorcontrib>Guillaume, P.</creatorcontrib><creatorcontrib>Raibaud, P.</creatorcontrib><creatorcontrib>Joulin, Y.</creatorcontrib><creatorcontrib>Lecomte, J.M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Alimentary pharmacology & therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Duval‐Iflah, Y.</au><au>Berard, H.</au><au>Baumer, P.</au><au>Guillaume, P.</au><au>Raibaud, P.</au><au>Joulin, Y.</au><au>Lecomte, J.M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of racecadotril and loperamide on bacterial proliferation and on the central nervous system of the newborn gnotobiotic piglet</atitle><jtitle>Alimentary pharmacology & therapeutics</jtitle><addtitle>Aliment Pharmacol Ther</addtitle><date>1999-12</date><risdate>1999</risdate><volume>13</volume><issue>s6</issue><spage>9</spage><epage>14</epage><pages>9-14</pages><issn>0269-2813</issn><eissn>1365-2036</eissn><abstract>Methods The effects of 4 days of oral administration of different doses of two drugs, an enkephalinase inhibitor (the antisecretory agent, racecadotril) and a μ‐receptor agonist (loperamide), on intestinal growth of a bacterial nonpathogenic strain (Escherichia coli E 404) and on the central nervous system (CNS) were compared in newborn gnotobiotic piglets.
Results The E. coli content of the proximal jejunum (segment S1) and the E. coli ratio of stomach:segment S1 were similar in the racecadotril (20 mg/kg b.d., n = 5) and control groups. In contrast, in the loperamide group (1 mg/kg b.d., n = 4), the E. coli content of segment S1 and the E. coli ratio stomach:S1 were both significantly higher than with racecadotril or control (P = 0.04 and 0.005, respectively, for E. coli content; P = 0.05 and 0.03, respectively, for stomach:S1). There were no clinical signs of neurotoxicity and no deaths with racecadotril given orally at a high dose of 130 mg/kg b.d. (n = 5) – nearly 60 times the paediatric dosage. In contrast, an equivalent high dose of loperamide (5 mg/kg b.d.) resulted in death in three out of four piglets.
Conclusions In contrast to loperamide, racecadotril did not induce bacterial overgrowth and did not produce central neurotoxicity.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>10646046</pmid><doi>10.1046/j.1365-2036.1999.00001.x-i1</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0269-2813 |
ispartof | Alimentary pharmacology & therapeutics, 1999-12, Vol.13 (s6), p.9-14 |
issn | 0269-2813 1365-2036 |
language | eng |
recordid | cdi_hal_primary_oai_HAL_hal_02696176v1 |
source | Wiley |
subjects | Animals Animals, Newborn Antidiarrheals - pharmacology Bacteria - drug effects Brain - drug effects Digestive System - microbiology Germ-Free Life Life Sciences Loperamide - pharmacology Loperamide - toxicity Neprilysin - antagonists & inhibitors Protease Inhibitors - pharmacology Swine Thiorphan - analogs & derivatives Thiorphan - pharmacology Thiorphan - toxicity |
title | Effects of racecadotril and loperamide on bacterial proliferation and on the central nervous system of the newborn gnotobiotic piglet |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T22%3A50%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20racecadotril%20and%20loperamide%20on%20bacterial%20proliferation%20and%20on%20the%20central%20nervous%20system%20of%20the%20newborn%20gnotobiotic%20piglet&rft.jtitle=Alimentary%20pharmacology%20&%20therapeutics&rft.au=Duval%E2%80%90Iflah,%20Y.&rft.date=1999-12&rft.volume=13&rft.issue=s6&rft.spage=9&rft.epage=14&rft.pages=9-14&rft.issn=0269-2813&rft.eissn=1365-2036&rft_id=info:doi/10.1046/j.1365-2036.1999.00001.x-i1&rft_dat=%3Cwiley_hal_p%3EAPT2%3C/wiley_hal_p%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4052-1cf3fdeeb99e1acf95ca46a0ac273cf0d85285dda24c9e7cb9b0838301ac51d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/10646046&rfr_iscdi=true |